FDA’s Draft Guidance for Data Monitoring Committees (DMCs)
How Veristat’s Proven DMC Expertise for Complex Trials Supports Patient Safety and Sponsor Success
Monthly FDA Guidance and Regulatory News Review - July 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Monthly FDA Guidance and Regulatory News Review - June 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
FSP/Resourcing: Meeting the Moment with Expert Resources
Clinical trial leaders in small and medium-sized biotech companies regularly find themselves at the...
Monthly FDA Guidance and Regulatory News Review - May 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Achieve Regulatory Excellence and Accelerate Your Clinical Trials with Veristat
Learn how Veristat’s multidisciplinary team helped sponsors navigate the complexities of global...
Webinar Q&A: How to Advance New Cancer Therapies in Alignment with FDA Project FrontRunner
In partnership with Clinical Leader, Veristat consulting, regulatory, and clinical experts gave a...
Monthly FDA Guidance and Regulatory News Review - April 2024
Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...
Harness the FDA's Project FrontRunner to Advance Your New Oncology Therapies
Are you interested in learning about the latest FDA initiative to accelerate the development of new...